Patients with TEFM variants present with a wide range of clinical presentations including neonatal lactic acidosis, epileptic encephalopathy, developmental delay and intellectual disability with nonspecific changes on brain MRI or mitochondrial myopathy with a treatable neuromuscular transmission defect. This evidence concerns the gene TEFM and Global developmental delay.